KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $2.49.

  • Cme's EPS (Basic) fell 79.68% to $2.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.33, marking a year-over-year increase of 839.45%. This contributed to the annual value of $9.69 for FY2024, which is 917.74% up from last year.
  • According to the latest figures from Q3 2025, Cme's EPS (Basic) is $2.49, which was down 79.68% from $2.81 recorded in Q2 2025.
  • Over the past 5 years, Cme's EPS (Basic) peaked at $2.81 during Q2 2025, and registered a low of $1.42 during Q2 2021.
  • In the last 5 years, Cme's EPS (Basic) had a median value of $2.24 in 2023 and averaged $2.17.
  • In the last 5 years, Cme's EPS (Basic) soared by 12521.74% in 2021 and then crashed by 2779.92% in 2022.
  • Quarter analysis of 5 years shows Cme's EPS (Basic) stood at $1.69 in 2021, then increased by 4.14% to $1.76 in 2022, then grew by 27.29% to $2.24 in 2023, then rose by 7.28% to $2.4 in 2024, then increased by 3.61% to $2.49 in 2025.
  • Its EPS (Basic) was $2.49 in Q3 2025, compared to $2.81 in Q2 2025 and $2.63 in Q1 2025.